ID   NTCP2_HUMAN             Reviewed;         348 AA.
AC   Q12908; A1L4F4; Q13839;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Ileal sodium/bile acid cotransporter;
DE   AltName: Full=Apical sodium-dependent bile acid transporter;
DE            Short=ASBT;
DE   AltName: Full=Ileal Na(+)/bile acid cotransporter;
DE   AltName: Full=Ileal sodium-dependent bile acid transporter;
DE            Short=IBAT;
DE            Short=ISBT;
DE   AltName: Full=Na(+)-dependent ileal bile acid transporter;
DE   AltName: Full=Sodium/taurocholate cotransporting polypeptide, ileal;
DE   AltName: Full=Solute carrier family 10 member 2;
GN   Name=SLC10A2; Synonyms=ASBT, ISBT, NTCP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-171 AND CD SER-290.
RC   TISSUE=Ileum;
RX   PubMed=7592981; DOI=10.1074/jbc.270.45.27228;
RA   Wong M.H., Oelkers P., Dawson P.A.;
RT   "Identification of a mutation in the ileal sodium-dependent bile acid
RT   transporter gene that abolishes transport activity.";
RL   J. Biol. Chem. 270:27228-27234(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS PBAM PRO-243 AND MET-262,
RP   AND VARIANT ALA-171.
RX   PubMed=9109432; DOI=10.1172/JCI119355;
RA   Oelkers P., Kirby L.C., Heubi J.E., Dawson P.A.;
RT   "Primary bile acid malabsorption caused by mutations in the ileal
RT   sodium-dependent bile acid transporter gene (SLC10A2).";
RL   J. Clin. Invest. 99:1880-1887(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-171.
RX   PubMed=12364586; DOI=10.1073/pnas.182412499;
RA   Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M.,
RA   Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P.,
RA   Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S.,
RA   Picard F.-P., Maurice K., Essioux L., Millasseau P., Grel P.,
RA   Debailleul V., Simon A.-M., Caterina D., Dufaure I., Malekzadeh K.,
RA   Belova M., Luan J.-J., Bouillot M., Sambucy J.-L., Primas G.,
RA   Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H.,
RA   Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M.,
RA   Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A.,
RA   Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J.,
RA   Sherbatich T., Riazanskay N., Rogaev E., Raeymaekers P., Aerssens J.,
RA   Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E.,
RA   Weinberger D.R., Cohen N., Cohen D.;
RT   "Genetic and physiological data implicating the new human gene G72 and
RT   the gene for D-amino acid oxidase in schizophrenia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13675-13680(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-171.
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-171.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RC   TISSUE=Blood;
RA   Stengelin S., Becker W., Maier M., Rosenberger J., Kramer W.;
RT   "Human ileal sodium-dependent bile acid transporter gene (promoter,
RT   exon 1 and intron 1).";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   GLYCOSYLATION AT ASN-10, MUTAGENESIS OF ASN-10 AND ASN-328, AND
RP   TOPOLOGY.
RX   PubMed=15350125; DOI=10.1021/bi049270a;
RA   Zhang E.Y., Phelps M.A., Banerjee A., Khantwal C.M., Chang C.,
RA   Helsper F., Swaan P.W.;
RT   "Topology scanning and putative three-dimensional structure of the
RT   extracellular binding domains of the apical sodium-dependent bile acid
RT   transporter (SLC10A2).";
RL   Biochemistry 43:11380-11392(2004).
RN   [9]
RP   VARIANTS ILE-98; ILE-159 AND ALA-171.
RX   PubMed=11742882; DOI=10.1161/hq1201.100262;
RA   Love M.W., Craddock A.L., Angelin B., Brunzell J.D., Duane W.C.,
RA   Dawson P.A.;
RT   "Analysis of the ileal bile acid transporter gene, SLC10A2, in
RT   subjects with familial hypertriglyceridemia.";
RL   Arterioscler. Thromb. Vasc. Biol. 21:2039-2045(2001).
RN   [10]
RP   VARIANTS ILE-98 AND ALA-171.
RX   PubMed=11589382; DOI=10.1080/003655201750422693;
RA   Montagnani M., Love M.W., Rossel P., Dawson P.A., Qvist P.;
RT   "Absence of dysfunctional ileal sodium-bile acid cotransporter gene
RT   mutations in patients with adult-onset idiopathic bile acid
RT   malabsorption.";
RL   Scand. J. Gastroenterol. 36:1077-1080(2001).
CC   -!- FUNCTION: Plays a critical role in the sodium-dependent
CC       reabsorption of bile acids from the lumen of the small intestine.
CC       Plays a key role in cholesterol metabolism.
CC   -!- SUBUNIT: Monomer and homodimer.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- DISEASE: Primary bile acid malabsorption (PBAM) [MIM:613291]: An
CC       intestinal disorder associated with chronic watery diarrhea,
CC       excess fecal bile acids, steatorrhea and interruption of the
CC       enterohepatic circulation of bile acids.
CC       {ECO:0000269|PubMed:9109432}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the bile acid:sodium symporter (BASS)
CC       (TC 2.A.28) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10417; AAC51870.1; -; mRNA.
DR   EMBL; U67674; AAC95398.1; -; Genomic_DNA.
DR   EMBL; U67669; AAC95398.1; JOINED; Genomic_DNA.
DR   EMBL; U67670; AAC95398.1; JOINED; Genomic_DNA.
DR   EMBL; U67671; AAC95398.1; JOINED; Genomic_DNA.
DR   EMBL; U67672; AAC95398.1; JOINED; Genomic_DNA.
DR   EMBL; U67673; AAC95398.1; JOINED; Genomic_DNA.
DR   EMBL; AE014294; AAN16026.1; -; Genomic_DNA.
DR   EMBL; AL161771; CAC39447.1; -; Genomic_DNA.
DR   EMBL; CH471085; EAX09074.1; -; Genomic_DNA.
DR   EMBL; BC130521; AAI30522.1; -; mRNA.
DR   EMBL; BC130523; AAI30524.1; -; mRNA.
DR   EMBL; Z54350; CAA91161.1; -; Genomic_DNA.
DR   CCDS; CCDS9506.1; -.
DR   PIR; I38655; I38655.
DR   RefSeq; NP_000443.1; NM_000452.2.
DR   UniGene; Hs.194783; -.
DR   ProteinModelPortal; Q12908; -.
DR   BioGrid; 112444; 1.
DR   STRING; 9606.ENSP00000245312; -.
DR   BindingDB; Q12908; -.
DR   ChEMBL; CHEMBL2778; -.
DR   DrugBank; DB00787; Aciclovir.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB03619; Deoxycholic Acid.
DR   DrugBank; DB02123; Glycochenodeoxycholic Acid.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   DrugBank; DB01586; Ursodeoxycholic acid.
DR   DrugBank; DB00577; Valaciclovir.
DR   GuidetoPHARMACOLOGY; 960; -.
DR   TCDB; 2.A.28.1.2; the bile acid:na(+) symporter (bass) family.
DR   iPTMnet; Q12908; -.
DR   PhosphoSitePlus; Q12908; -.
DR   BioMuta; SLC10A2; -.
DR   DMDM; 322510055; -.
DR   PaxDb; Q12908; -.
DR   PeptideAtlas; Q12908; -.
DR   PRIDE; Q12908; -.
DR   DNASU; 6555; -.
DR   Ensembl; ENST00000245312; ENSP00000245312; ENSG00000125255.
DR   GeneID; 6555; -.
DR   KEGG; hsa:6555; -.
DR   UCSC; uc001vpy.4; human.
DR   CTD; 6555; -.
DR   DisGeNET; 6555; -.
DR   GeneCards; SLC10A2; -.
DR   HGNC; HGNC:10906; SLC10A2.
DR   HPA; HPA004795; -.
DR   MalaCards; SLC10A2; -.
DR   MIM; 601295; gene.
DR   MIM; 613291; phenotype.
DR   neXtProt; NX_Q12908; -.
DR   OpenTargets; ENSG00000125255; -.
DR   PharmGKB; PA318; -.
DR   eggNOG; KOG2718; Eukaryota.
DR   eggNOG; COG0385; LUCA.
DR   GeneTree; ENSGT00550000074505; -.
DR   HOGENOM; HOG000234524; -.
DR   HOVERGEN; HBG006537; -.
DR   InParanoid; Q12908; -.
DR   KO; K14342; -.
DR   OMA; NSCVDNA; -.
DR   OrthoDB; EOG091G0GT5; -.
DR   PhylomeDB; Q12908; -.
DR   TreeFam; TF315811; -.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   GeneWiki; SLC10A2; -.
DR   GenomeRNAi; 6555; -.
DR   PRO; PR:Q12908; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000125255; -.
DR   CleanEx; HS_SLC10A2; -.
DR   Genevisible; Q12908; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008508; F:bile acid:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR002657; BilAc:Na_symport/Acr3.
DR   InterPro; IPR004710; Bilac:Na_transpt.
DR   InterPro; IPR030207; SLC10A2.
DR   PANTHER; PTHR10361; PTHR10361; 1.
DR   PANTHER; PTHR10361:SF49; PTHR10361:SF49; 1.
DR   Pfam; PF01758; SBF; 1.
DR   TIGRFAMs; TIGR00841; bass; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Glycoprotein; Ion transport;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    348       Ileal sodium/bile acid cotransporter.
FT                                /FTId=PRO_0000052339.
FT   TOPO_DOM      1     28       Extracellular. {ECO:0000255}.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TOPO_DOM     50     82       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     83    103       Helical. {ECO:0000255}.
FT   TOPO_DOM    104    126       Extracellular. {ECO:0000255}.
FT   TRANSMEM    127    147       Helical. {ECO:0000255}.
FT   TOPO_DOM    148    157       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TOPO_DOM    179    195       Extracellular. {ECO:0000255}.
FT   TRANSMEM    196    216       Helical. {ECO:0000255}.
FT   TOPO_DOM    217    224       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   TOPO_DOM    246    284       Extracellular. {ECO:0000255}.
FT   TRANSMEM    285    305       Helical. {ECO:0000255}.
FT   TOPO_DOM    306    348       Cytoplasmic. {ECO:0000255}.
FT   SITE        328    328       Not glycosylated.
FT   MOD_RES     335    335       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70172}.
FT   CARBOHYD     10     10       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15350125}.
FT   VARIANT      98     98       V -> I (in dbSNP:rs55971546).
FT                                {ECO:0000269|PubMed:11589382,
FT                                ECO:0000269|PubMed:11742882}.
FT                                /FTId=VAR_024837.
FT   VARIANT     159    159       V -> I (in dbSNP:rs60380298).
FT                                {ECO:0000269|PubMed:11742882}.
FT                                /FTId=VAR_024838.
FT   VARIANT     171    171       S -> A (in dbSNP:rs188096).
FT                                {ECO:0000269|PubMed:11589382,
FT                                ECO:0000269|PubMed:11742882,
FT                                ECO:0000269|PubMed:12364586,
FT                                ECO:0000269|PubMed:15057823,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7592981,
FT                                ECO:0000269|PubMed:9109432}.
FT                                /FTId=VAR_004613.
FT   VARIANT     243    243       L -> P (in PBAM; abolishes taurocholate
FT                                transport; dbSNP:rs121917848).
FT                                {ECO:0000269|PubMed:9109432}.
FT                                /FTId=VAR_004614.
FT   VARIANT     262    262       T -> M (in PBAM; abolishes taurocholate
FT                                transport; dbSNP:rs72547505).
FT                                {ECO:0000269|PubMed:9109432}.
FT                                /FTId=VAR_004615.
FT   VARIANT     290    290       P -> S (in a patient with Crohn disease;
FT                                abolishes taurocholate transport;
FT                                dbSNP:rs56398830).
FT                                {ECO:0000269|PubMed:7592981}.
FT                                /FTId=VAR_004616.
FT   MUTAGEN      10     10       N->D: Abolishes glycosylation.
FT                                {ECO:0000269|PubMed:15350125}.
FT   MUTAGEN     328    328       N->D: No effect on glycosylation.
FT                                {ECO:0000269|PubMed:15350125}.
SQ   SEQUENCE   348 AA;  37714 MW;  9794EAA77C3EC4F9 CRC64;
     MNDPNSCVDN ATVCSGASCV VPESNFNNIL SVVLSTVLTI LLALVMFSMG CNVEIKKFLG
     HIKRPWGICV GFLCQFGIMP LTGFILSVAF DILPLQAVVV LIIGCCPGGT ASNILAYWVD
     GDMDLSVSMT TCSTLLALGM MPLCLLIYTK MWVDSGSIVI PYDNIGTSLV SLVVPVSIGM
     FVNHKWPQKA KIILKIGSIA GAILIVLIAV VGGILYQSAW IIAPKLWIIG TIFPVAGYSL
     GFLLARIAGL PWYRCRTVAF ETGMQNTQLC STIVQLSFTP EELNVVFTFP LIYSIFQLAF
     AAIFLGFYVA YKKCHGKNKA EIPESKENGT EPESSFYKAN GGFQPDEK
//
